Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse

被引:72
|
作者
Waterman, SA [1 ]
Lang, B [1 ]
NewsomDavis, J [1 ]
机构
[1] UNIV OXFORD, JOHN RADCLIFFE HOSP, INST MOL MED, DEPT PHARMACOL, OXFORD OX3 9DU, ENGLAND
关键词
D O I
10.1002/ana.410420204
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Somatic muscle weakness and autonomic symptoms characterize the autoimmune Lambert-Eaton myasthenic syndrome (LEMS). The former results from IgG autoantibody-mediated down-regulation of P/Q-type voltage-gated calcium channels at motor nerve terminals and consequent reduction in acetylcholine release; the basis for the autonomic symptoms is unknown. Using omega-conocoxins GVIA and MVIIC and omega-agatoxin IVA that block N-, Q-, and P-type channels, we investigated ex vivo the calcium channels subserving transmitter release from postganglionic parasympathetic neurons in the bladder and from postganglionic sympathetic neurons in the vas deferens of mice injected with IgG from LEMS patients or from controls. Calcium influx through N-, P-, and Q-type channels subserved transmitter release from parasympathetic and sympathetic neurons in control mice. In test mice, the component of transmitter release subserved by P-type channels was abolished by four of four LEMS IgG preparations, that subserved by Q-type channels was significantly reduced by three, and that subserved by N-type channels by one. Thus, LEMS IgG impairs transmitter release from parasympathetic and sympathetic neurons through down-regulation of one or more subtypes of voltage-gated calcium channels. The results suggest chat antibody-mediated interference with specific ion channel function may also underlie autonomic dysfunction occurring in other autoimmune diseases.
引用
收藏
页码:147 / 156
页数:10
相关论文
共 50 条
  • [1] Autonomic dysfunction in Lambert-Eaton myasthenic syndrome
    Waterman, SA
    CLINICAL AUTONOMIC RESEARCH, 2001, 11 (03) : 145 - 154
  • [2] AUTONOMIC DYSFUNCTION IN LAMBERT-EATON MYASTHENIC SYNDROME
    KHURANA, RK
    KOSKI, CL
    MAYER, RF
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1988, 85 (01) : 77 - 86
  • [3] Autonomic dysfunction in Lambert-Eaton myasthenic syndrome
    Sally A. Waterman
    Clinical Autonomic Research, 2001, 11 : 145 - 154
  • [4] VGCC antibodies and Lambert-Eaton Myasthenic Syndrome
    Verschuuren, Jan
    NEUROMUSCULAR DISORDERS, 2006, 16 : S103 - S103
  • [5] ABNORMALITIES OF AUTONOMIC FUNCTION IN THE LAMBERT-EATON MYASTHENIC SYNDROME
    HEATH, JP
    EWING, DJ
    CULL, RE
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1988, 51 (03): : 436 - 439
  • [6] Lambert-Eaton Myasthenic Syndrome
    Kesner, Vita G.
    Oh, Shin J.
    Dimachkie, Mazen M.
    Barohn, Richard J.
    NEUROLOGIC CLINICS, 2018, 36 (02) : 379 - +
  • [7] LAMBERT-EATON MYASTHENIC SYNDROME
    JABLECKI, C
    MUSCLE & NERVE, 1984, 7 (03) : 250 - 257
  • [8] Lambert-Eaton myasthenic syndrome
    Chiang, Yi Zhen
    Tan, Kian Tjon
    Hart, Ian K.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2009, 70 (03) : 168 - 169
  • [9] LAMBERT-EATON MYASTHENIC SYNDROME
    IRITA, K
    SATOH, M
    AKATA, T
    YANO, T
    TAKAHASHI, S
    YOSHITAKE, J
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1990, 37 (08): : 944 - 944
  • [10] Lambert-eaton myasthenic syndrome
    John Newsom-Davis
    Current Treatment Options in Neurology, 2001, 3 (2) : 127 - 131